You are viewing: Italy Humanized Mouse and Rat Model Market analysis

The Italy Humanized Mouse and Rat Model Market was valued at $4.1 Million in 2025 and projected to reach to $5.9 Million by 2030, representing a compound annual growth rate of 7.4%. Italy's humanized mouse and rat model market demonstrates steady growth potential within the broader European preclinical research landscape.

Italy Humanized Mouse and Rat Model Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Humanized Mouse and Rat Model Market Trends and Insights

  • Valued at $4.1 million in 2025, Italy's market is expected to expand to $5.9 million by 2030, reflecting a compound annual growth rate of 7.4%.
  • This growth trajectory in Italy is driven by increasing investment in pharmaceutical development, rising demand for advanced in vivo disease models, and Italy's strengthening biotechnology research ecosystem. The Italian market benefits from the country's established pharmaceutical and academic research institutions, which increasingly adopt humanized mouse and rat models for drug efficacy and safety testing.
  • Italy's participation in European regulatory frameworks and collaborative research initiatives further supports market expansion.
  • Between 2025 and 2030, Italy is expected to see heightened adoption of these models across oncology, immunology, and infectious disease research programs, positioning the country as a growing contributor to Europe's preclinical research landscape..

Key Market Statistics

  • CAGR (2025-2030) 7.4% CAGR
  • Market Size, 2025 ~USD 4.1 Million
  • Forecast, 2030 ~USD 5.9 Million
  • Country Italy

Italy Humanized Mouse and Rat Model Market Overview

Market Valuation :

Italy's humanized mouse and rat model market is valued at $4.1 million in 2025, with projected growth to $5.9 million by 2030, representing a 7.4% CAGR specific to the Italian market.

Growth Drivers in Italy :

Italy's market expansion is fueled by increased pharmaceutical R&D investments, growing adoption of preclinical testing models, and strengthened regulatory compliance requirements within Italian and EU research institutions.

Regional Position :

As a specialized segment within Europe's preclinical research infrastructure, Italy represents a key market for humanized model suppliers targeting Southern European pharmaceutical and biotech companies.

Research Infrastructure :

Italy's robust academic research ecosystem and established pharmaceutical sector create sustained demand for advanced preclinical models among Italian universities, contract research organizations, and biotech firms.

Italy Humanized Mouse and Rat Model Market Dynamics

  • The 7.4% CAGR reflects increasing pharmaceutical development activities and heightened regulatory scrutiny driving demand for advanced animal models.
  • Italian research institutions and pharmaceutical companies are progressively adopting humanized models to accelerate drug discovery and reduce development timelines. Looking ahead to 2030, Italy's market will benefit from continued EU investment in life sciences research, expansion of biotech clusters, and growing collaboration between Italian academic centers and international pharmaceutical firms.
  • The market's trajectory suggests sustained opportunities for suppliers offering specialized humanized models tailored to Italian and Southern European research needs..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Italy's humanized mouse and rat model market is valued at $4.1 million in 2025 and is projected to reach $5.9 million by 2030, representing a 7.4% CAGR.
    • Italy's pharmaceutical and academic research sectors are increasingly adopting humanized models to accelerate drug development and meet European regulatory requirements.
    • Italy's participation in collaborative European research networks enhances access to advanced preclinical technologies and expands market opportunities.
    • Between 2025 and 2030, Italy is expected to experience steady growth driven by investments in biotechnology infrastructure and rising demand for personalized medicine research.

    Humanized Mouse and Rat Model Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS AND CDMOS) (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.2% from 2025 to 2030
    Largest Segment HUMANIZED MOUSE MODELS (Type)
    Market Size Base Year (Billions) ~USD 0.28 (2025)
    Revenue Forecast (Billions) ~USD 0.41 (2030)
    Segments Covered Type, End User, Application

    Italy Humanized Mouse and Rat Model Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Type

    • Blt Humanized Mouse Models
    • Cd34 Humanized Mouse Models
    • Cell-Based Humanized Mouse Models
    • Genetic Humanized Mouse Models
    • Humanized Mouse Models
    • Humanized Rat Models
    • Pbmc Humanized Mouse Models

    By End User

    • Academic & Research Institutes
    • Academic And Research Institutes
    • Contract Research Organizations And Contract Development And Manufacturing Organizations (Cros And Cdmos)
    • Cros & Cdmos
    • Cros And Cdmos
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical And Biotechnology Companies

    By Application

    • Hematopoiesis
    • Immunology And Infectious Diseases
    • Neuroscience
    • Oncology
    • Other Applications
    • Toxicology

    ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.710.720.750.790.830.870.90.944.6
    CROS AND CDMOS1.211.271.371.51.631.771.912.068.5
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES2.662.752.933.153.373.63.844.096.9
    TOTAL4.574.735.065.455.836.236.657.097

    Target Audience

    • Italian Pharmaceutical Companies : Require detailed market data to benchmark preclinical research capabilities, optimize R&D budgets, and identify opportunities for humanized model adoption in drug development pipelines.
    • Contract Research Organizations (CROs) in Italy : Need Italy-specific market insights to expand service offerings, justify investments in humanized model capabilities, and compete effectively within the Italian and Southern European preclinical market.
    • Italian Academic Research Institutions : Seek market intelligence to secure funding, justify equipment investments, and demonstrate the relevance of humanized model research within Italy's competitive academic research landscape.
    • International Suppliers & Distributors : Require Italy market data to evaluate market entry feasibility, identify local partnership opportunities, and develop targeted sales strategies for the Italian preclinical research sector.
    • Italian Biotech and Life Sciences Investors : Need comprehensive market analysis to assess investment opportunities, evaluate portfolio company growth potential, and understand market dynamics within Italy's emerging biotech ecosystem.

    Key Companies in the Italy Humanized Mouse and Rat Model Market

    CompanyHQOwnershipStrongest segments
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    THE JACKSON LABORATORYUnited StatesFoundation/Charitable InstitutionMouse breeding and colony management,Phenotyping, efficacy testing, and genetic research services,Genetic resources, software, and data,
    INOTIVUnited StatesPublic CompanyResearch Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
    GENOWAYFrancePublic CompanyCustom mouse models (KO/KI and humanized),Custom rat models,Engineered cell lines,
    JSR CORPORATIONJapanPrivate CompanyDigital Solutions (lithography, photoresists, CMP, display and packaging materials),Plastics / Synthetic Resins (ABS, AES, AS, ASA and related resins),Life Sciences (diagnostic and research reagents, bioprocess materials, drug discovery support),
    CHAMPIONS ONCOLOGY, INC.United StatesPublic CompanyTumorgraft / PDX-based translational oncology services,Personalized cancer care services,Lumin Bioinformatics and data-driven software,
    ONCODESIGN SERVICESFrancePublic CompanyPrecision oncology and immuno-oncology (OPM-101, OPM-102),Neurodegeneration (OPM-201, Parkinson’s),Radiotheranostic portfolio for digestive and pancreatic cancers,

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a public company founded in 1947 in the United States with 19,000 employees.

    THE JACKSON LABORATORY

    The Jackson Laboratory is a foundation-based charitable institution founded in 1929 in the United States with 2,100 employees.

    INOTIV

    Inotiv is a public company founded in 1974 in the United States with 1,996 employees.

    GENOWAY

    Genoway is a public company founded in 1999 in France with 157 employees.

    JSR CORPORATION

    JSR Corporation is a private company founded in 1948 in Japan with 7,997 employees.

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology, Inc. is a public company founded in 1985 in the United States with 214 employees.

    ONCODESIGN SERVICES

    Oncodesign Services is a public company founded in 1995 in France.

    Reasons to Buy this Report

    • Italy-Specific Market Sizing : Obtain precise valuation data for Italy's humanized model market ($4.1M in 2025) with accurate 2030 forecasts, enabling targeted investment and resource allocation decisions for Italian operations.
    • Competitive Landscape Intelligence : Understand Italy's unique competitive dynamics, supplier positioning, and market consolidation trends specific to the Italian preclinical research sector and Southern European demand patterns.
    • Growth Opportunity Assessment : Identify the 7.4% CAGR growth drivers specific to Italy, including regulatory changes, pharmaceutical investment trends, and research infrastructure developments affecting market expansion through 2030.
    • Strategic Market Entry Planning : Develop Italy-focused go-to-market strategies with insights into local customer preferences, institutional partnerships, and distribution channels within Italian academic and commercial research sectors.
    • Investment Decision Support : Make informed decisions on Italian market expansion, partnership development, and resource investment with comprehensive data on market trajectory, customer segments, and revenue potential.

    Frequently asked questions

    What is the current market size of humanized mouse and rat models in Italy?

    Italy's humanized mouse and rat model market was valued at $4.1 million in 2025 and is expected to grow to $5.9 million by 2030.

    What is the projected growth rate for Italy's humanized mouse and rat model market?

    Italy's market is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2030.

    Which sectors in Italy are driving demand for humanized mouse and rat models?

    Italy's pharmaceutical companies, academic research institutions, and biotechnology firms are primary drivers, particularly in oncology, immunology, and infectious disease research.

    How does Italy's market compare to the broader European market?

    Italy represents a growing segment within Europe's preclinical research market, with steady adoption supported by the country's established research infrastructure and regulatory alignment with EU standards.

    What factors are supporting market growth in Italy between 2025 and 2030?

    Key growth factors include increased pharmaceutical R&D investment, rising adoption of personalized medicine approaches, Italy's participation in European research collaborations, and strengthened biotechnology infrastructure.

    RESEARCH METHODOLOGY

    The research study used secondary sources, directories, and databases to identify and collect valuable information to analyze the global humanized mouse and rat model market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size was estimated through secondary research (top-down and bottom-up), followed by data triangulation with inputs from industry experts to determine the final market size.

    Secondary Research

    Secondary research was used to identify and collect information for the technical, market-oriented, and commercial study of the humanized mouse and rat model market. The secondary sources used for this study include the American Association for Cancer Research (AACR), American Association for Laboratory Animal Science (AALAS), European Society for Medical Oncology (ESMO), European Association for Cancer Research (EACR), Humanized Mouse Resource (HMR), National Center for Biotechnology Information (NCBI), and Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

    Academic Journals and Company Websites; corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used to obtain major information about key market players and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analyzed to determine the market size of the global humanized mouse and rat model market, which was further validated through primary research.

    Primary Research

    Primary research was conducted after acquiring basic knowledge about the global humanized mouse and rat model market through secondary research. A series of primary interviews were conducted with market experts from the demand side, including professionals from the pharmaceutical and biopharmaceutical industries and academic institutions. Additionally, interviews were held with individuals from the supply side, such as C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners. The primary interviews were conducted across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants. This data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The breakdown of the primary respondents is given below.

    Humanized Mouse and Rat Model Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Top-down and bottom-up approaches were used to estimate and validate the total size of the humanized mouse and rat model market. These methods were also used extensively to estimate the size of various subsegments in the market.

    Humanized Mouse and Rat Model Market

    Data Triangulation

    After determining the market size from the above estimation process, the total market was divided into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides.

    Market Definition

    A humanized mouse and rat model is an immunodeficient organism genetically engineered to study immune responses to drugs or identify potential disease targets. These models are widely used to study human diseases and genes. Researchers in both academia and industry, along with clinicians, extensively use humanized mouse and rat models in their research applications. Humanized mouse and rat models are beneficial tools for immuno-oncology and infectious disease research. They have improved the ability to predict human responses to new therapeutics in clinical development.

    Stakeholders

    • Research and consulting firms
    • Biopharmaceutical manufacturers
    • Pharmaceutical manufacturers
    • Mouse model and service companies
    • Government and private research institutes
    • Manufacturers and suppliers of animal care products
    • Clinical research organizations (CROs)
    • Academic and research institutes
    • Venture capitalists
    • Laboratory animal care associations
    • Public and private animal health agencies

    Report Objectives

     

    To define, describe, and forecast the humanized mouse and rat model market by type, application, end user, and region

    To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)

    • To analyze the micromarkets1 concerning individual growth trends, prospects, and contributions to the overall humanized mouse and rat model market
    • To assess the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments for North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
    • To profile the key players and analyze their market shares and core competencies2
    • To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

     

    Get the Full Humanized Mouse and Rat Model Market Report

    Full forecast, segment splits, and company analysis for all Humanized Mouse and Rat Model Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status